http://www.epmmagazine.com/topics/opinion/index.rss en-us © 2015 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved. Fri, 23 Oct 2015 10:07:00 GMT Robert Gaertner Robert Gaertner, director strategy, Veeva QualityDocs Europe, looks at the way that digitisation has changed life sciences and what the future holds, including technology development and upcoming regulatory requirements http://www.epmmagazine.com/opinion/quality-management/ http://www.epmmagazine.com/opinion/quality-management/ Fri, 23 Oct 2015 10:07:00 GMT Sylke Grootoonk Derek Hill Sylke Grootoonk and Derek Hill, IXICO, talks about how to effectively manage chronic diseases, biomarkers and digital health http://www.epmmagazine.com/opinion/disease-management-biomarkers-to-digital-health/ http://www.epmmagazine.com/opinion/disease-management-biomarkers-to-digital-health/ Thu, 22 Oct 2015 14:42:00 GMT Jörg Gierds Jörg Gierds, Fette Compacting looks at the rising demands on tablet presses for highly potent agents and explains how efficiency can be achieved through seamless containment http://www.epmmagazine.com/opinion/seamless-transitions/ http://www.epmmagazine.com/opinion/seamless-transitions/ Thu, 22 Oct 2015 08:46:14 GMT Simon Portman Simon Portman, Marks & Clerk Solicitors, outlines the work the company does advising pharmaceutical companies on intellectual property issues http://www.epmmagazine.com/opinion/simon-portman-marks-clerk-solicitors-outlines-the-work-the-c/ http://www.epmmagazine.com/opinion/simon-portman-marks-clerk-solicitors-outlines-the-work-the-c/ Wed, 21 Oct 2015 11:02:38 GMT The solution to Anti-Microbial Resistance (AMR) is widely thought to lie in the development of new antibiotics and diagnostic tests however Helen Lambert disagrees http://www.epmmagazine.com/opinion/expert-says-resistance-to-antibiotics-is-a-consequence-of-h/ http://www.epmmagazine.com/opinion/expert-says-resistance-to-antibiotics-is-a-consequence-of-h/ Tue, 20 Oct 2015 13:18:00 GMT Richard Anderson Crawford Healthcare’s Richard Anderson discusses how new approaches to antimicrobial resistance and silver-based wound dressings could relieve the burden on the NHS http://www.epmmagazine.com/opinion/silver-service/ http://www.epmmagazine.com/opinion/silver-service/ Mon, 19 Oct 2015 16:11:18 GMT The European Federation of Pharmaceutical Industries and Associations discusses the importance of its Partners in Research initiative to boost research in healthcare http://www.epmmagazine.com/opinion/european-union/ http://www.epmmagazine.com/opinion/european-union/ Mon, 19 Oct 2015 10:10:05 GMT Dr David Roblin Dr David Roblin, chief operating officer and director of scientific translation at the Francis Crick Institute in London, talks to EPM about the Institute’s recent partnership with GSK that will address a number of disease areas http://www.epmmagazine.com/opinion/david-roblin-francis-crick-institute-in-london/ http://www.epmmagazine.com/opinion/david-roblin-francis-crick-institute-in-london/ Mon, 12 Oct 2015 14:19:00 GMT Lu Rahman Featuring Roxy Music, The Verve, Jam, Dandy Warhols and Blur http://www.epmmagazine.com/opinion/five-songs-about-pharma/ http://www.epmmagazine.com/opinion/five-songs-about-pharma/ Fri, 09 Oct 2015 10:38:00 GMT Vaishali Kamat Vaishali Kamat, head of digital health at Cambridge Consultants, talks product design and development for the digital side of health http://www.epmmagazine.com/opinion/in-profile-vaishali-kamat-cambridge-consultants/ http://www.epmmagazine.com/opinion/in-profile-vaishali-kamat-cambridge-consultants/ Thu, 08 Oct 2015 10:32:00 GMT Rick Valencia Rick Valencia, Qualcomm Life, explains how wearable technologies enhance the effectiveness of clinical trials http://www.epmmagazine.com/opinion/what-to-wear/ http://www.epmmagazine.com/opinion/what-to-wear/ Wed, 07 Oct 2015 12:30:00 GMT Matt Mollan Julien Meissonnier Matt Mollan and Julien Meissonnier, Catalent provide expertise on strategies to optimise API performance for oral delivery dosage forms http://www.epmmagazine.com/opinion/optimum-performance/ http://www.epmmagazine.com/opinion/optimum-performance/ Wed, 07 Oct 2015 10:00:00 GMT Extract Technology According to Extract Technology there are five questions you need to ask yourself before purchasing a high potency containment system http://www.epmmagazine.com/opinion/high-five/ http://www.epmmagazine.com/opinion/high-five/ Wed, 07 Oct 2015 00:00:00 GMT Dr Siddharth Chachad Dr. Parvinder Punia ELC’s Dr Parvinder Punia and Dr Siddharth Chachad discuss global and regional vaccine programmes http://www.epmmagazine.com/opinion/discussing-vaccine-programs-with-elc/ http://www.epmmagazine.com/opinion/discussing-vaccine-programs-with-elc/ Mon, 05 Oct 2015 09:26:31 GMT Fernando Diez Fernando Diez, business development manager of Qualicaps, explains the advantages of the hard capsule dosage form in protecting drugs from light radiation http://www.epmmagazine.com/opinion/the-hard-line/ http://www.epmmagazine.com/opinion/the-hard-line/ Fri, 02 Oct 2015 15:20:00 GMT Graham Reynolds Graham Reynolds, West Pharmaceutical Services, looks at embracing the connected health movement and wearables in the management of chronic diseases http://www.epmmagazine.com/opinion/graham-reynolds-west-pharmaceutical-services-looks-at-embrac/ http://www.epmmagazine.com/opinion/graham-reynolds-west-pharmaceutical-services-looks-at-embrac/ Wed, 30 Sep 2015 15:35:00 GMT Stephen Brown Stephen Brown, Encap Drug Delivery, a division of Capsugel Dosage Form Solutions describes why the safe manufacturing of high potency drugs requires a specialised approach http://www.epmmagazine.com/opinion/high-potency/ http://www.epmmagazine.com/opinion/high-potency/ Wed, 30 Sep 2015 11:20:00 GMT Peter Sheppard Peter Sheppard, Genpact, explains how reimagining operations helps pharmaceutical companies refocus resources http://www.epmmagazine.com/opinion/think-tank/ http://www.epmmagazine.com/opinion/think-tank/ Tue, 29 Sep 2015 16:18:00 GMT Lu Rahman Lu Rahman discusses digital revolution and the life sciences sector http://www.epmmagazine.com/opinion/intelligent-thinking-the-digital-revolution/ http://www.epmmagazine.com/opinion/intelligent-thinking-the-digital-revolution/ Tue, 29 Sep 2015 15:59:00 GMT Alastair Smith Alastair Smith, Avacta Life Sciences, outlines the company’s work developing engineered alternatives to antibodies http://www.epmmagazine.com/opinion/in-profile/ http://www.epmmagazine.com/opinion/in-profile/ Mon, 28 Sep 2015 16:28:17 GMT Y. Shashidhar, partner & managing director, South Asia, Middle East & North Africa, Frost & Sullivan talks about how the local production of insulin from Novo Nordisk’s new plant in Iran could impact the pharma market http://www.epmmagazine.com/opinion/iran-s-insulin-production-and-how-it-affects-pharma/ http://www.epmmagazine.com/opinion/iran-s-insulin-production-and-how-it-affects-pharma/ Mon, 28 Sep 2015 09:47:49 GMT Breakthroughs in cancer pose the ‘Who pays?’ question, says Dr Neil Murray, Redx Pharma http://www.epmmagazine.com/opinion/who-s-footing-the-bill-for-cancer/ http://www.epmmagazine.com/opinion/who-s-footing-the-bill-for-cancer/ Thu, 24 Sep 2015 12:28:36 GMT Jörg Gierds Jörg Gierds, Fette Compacting, says that training of tablet press operators will help manufacturers stay on the right side of the US Food and Drug Administration (FDA) http://www.epmmagazine.com/opinion/best-practice-for-maximum-tablet-quality/ http://www.epmmagazine.com/opinion/best-practice-for-maximum-tablet-quality/ Wed, 23 Sep 2015 09:33:59 GMT Rachel Griffiths Rachel Griffiths, PCI, advises on maximising clinical supply chain efficiency for biologics http://www.epmmagazine.com/opinion/maximising-clinical-supply-chain-efficiency-for-biologics/ http://www.epmmagazine.com/opinion/maximising-clinical-supply-chain-efficiency-for-biologics/ Wed, 23 Sep 2015 09:19:00 GMT Muriel Berthier Denis McMillan Muriel Berthier and Denis McMillan, PAREXEL, discuss the key factors for achieving more reliable feasibility in clinical trials http://www.epmmagazine.com/opinion/making-feasibility-more-reliable-in-clinical-trials/ http://www.epmmagazine.com/opinion/making-feasibility-more-reliable-in-clinical-trials/ Tue, 22 Sep 2015 11:11:37 GMT John Welch John Welch, Butterworth Laboratories, urges pharmaceutical manufacturers to prepare sooner rather than later for the impending changes to elemental impurities requirements http://www.epmmagazine.com/opinion/elemental-impurities-in-marketed-products/ http://www.epmmagazine.com/opinion/elemental-impurities-in-marketed-products/ Tue, 22 Sep 2015 10:55:00 GMT John Challenger John Challenger, WH Partnership, emphasises the importance of integrating process plant and cleanrooms for successful pharmaceutical production http://www.epmmagazine.com/opinion/meeting-expectations-through-plant-and-cleanrooms-integratio/ http://www.epmmagazine.com/opinion/meeting-expectations-through-plant-and-cleanrooms-integratio/ Mon, 21 Sep 2015 14:59:00 GMT Nada Giuffrida Kym Ellis Nada Giuffrida and Kym Ellis, Hallam Internet, offer advice on how to redefine pharmaceutical digital marketing strategies http://www.epmmagazine.com/opinion/strategic-thinking-how-pharma-can-benefit-from-a-digital-mar/ http://www.epmmagazine.com/opinion/strategic-thinking-how-pharma-can-benefit-from-a-digital-mar/ Fri, 11 Sep 2015 15:25:00 GMT Capsugel’s Steven Facer says prioritisation of quality and regulatory compliance from the start is key to achieving long-term gains for emerging markets http://www.epmmagazine.com/opinion/Quality-first-in-development-and-manufacturing/ http://www.epmmagazine.com/opinion/Quality-first-in-development-and-manufacturing/ Tue, 08 Sep 2015 09:41:00 GMT Paul Clewlow Dr. Paul Clewlow, Sygnature Discovery, talks to EPM about the company’s successful track record in discovering medicines for the benefit of “patients with debilitating diseases such as cancer” http://www.epmmagazine.com/opinion/sygnature-scientists-are-named-inventors-on-over-50-drug-pat/ http://www.epmmagazine.com/opinion/sygnature-scientists-are-named-inventors-on-over-50-drug-pat/ Thu, 03 Sep 2015 10:14:50 GMT Professor Sam Salek Professor Sam Salek, School of Medical and Life Sciences, University of Hertfordshire, calls for a “universal framework” to speed up the disjointed decision-making process around the commissioning of new drugs http://www.epmmagazine.com/opinion/solving-the-global-benefit-risk-assessment-dilemma/ http://www.epmmagazine.com/opinion/solving-the-global-benefit-risk-assessment-dilemma/ Thu, 03 Sep 2015 08:50:45 GMT